Imagion Biosystems (ASX:IBX) FCF Yield % : -302.96 (As of Jun. 23, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Imagion Biosystems FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Imagion Biosystems's Trailing 12-Month Free Cash Flow is A$-8.51 Mil, and Market Cap is A$2.81 Mil. Therefore, Imagion Biosystems's FCF Yield % for today is -302.96%.

The historical rank and industry rank for Imagion Biosystems's FCF Yield % or its related term are showing as below:

ASX:IBX' s FCF Yield % Range Over the Past 10 Years
Min: -377.08 Med: -47.83 Max: -3.1
Current: -302.96

During the past 7 years, the highest FCF Yield % of Imagion Biosystems was -3.10%. The lowest was -377.08%. And the median was -47.83%.

ASX:IBX's FCF Yield % is ranked worse than
96.55% of 232 companies
in the Medical Diagnostics & Research industry
Industry Median: -3.36 vs ASX:IBX: -302.96

Imagion Biosystems's FCF Margin % for the quarter that ended in Dec. 2023 was -363.81%.

Imagion Biosystems FCF Yield % Historical Data

The historical data trend for Imagion Biosystems's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imagion Biosystems FCF Yield % Chart

Imagion Biosystems Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-32.81

-3.20

-6.20

-31.89

-73.39

Imagion Biosystems Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial									-10.69	-33.09	-26.55	-64.70	-42.50

Competitive Comparison of Imagion Biosystems's FCF Yield %

For the Diagnostics & Research subindustry, Imagion Biosystems's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Imagion Biosystems's FCF Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Imagion Biosystems's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Imagion Biosystems's FCF Yield % falls into.

Imagion Biosystems FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Imagion Biosystems's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-8.506	/	11.5895075
	=	-73.39%

Imagion Biosystems's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-2.463	*	2	/	11.5895075
	=	-42.50%

Imagion Biosystems FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Imagion Biosystems FCF Yield % Related Terms

Thank you for viewing the detailed overview of Imagion Biosystems's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Imagion Biosystems (ASX:IBX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Imagion Biosystems Ltd (ASX:IBX) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

5601 Oberlin Drive, Suite 100, San Diego, CA, USA, 92121

Website

https://www.imagionbiosystems.com

Imagion Biosystems Ltd operates in the field of non-invasive detection of specific solid tumor cancers by use of magnetic nanoparticles. The company only operating segment - Research and Development. Its principal business activities consist of nanotechnology, biotechnology, cancer diagnostics and medical imaging using Superparamagnetic Relaxometry. In addition, the company is engaged in the research and development of its clinical phase lead product which is intended for the detection and staging of metastatic HER2 breast cancer.

Imagion Biosystems (ASX:IBX) Headlines

No Headlines